14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 ATOS stock ended at $1.70. This is 1.16% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 6.59% from a day low at $1.67 to a day high of $1.78.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
Dec 29, 2016 $15.84 $16.68 $15.60 $15.72 2 772
Dec 28, 2016 $16.80 $17.04 $15.84 $16.32 4 216
Dec 27, 2016 $16.80 $17.16 $16.08 $16.44 2 991
Dec 23, 2016 $17.28 $18.48 $15.72 $16.56 14 900
Dec 22, 2016 $17.40 $17.40 $15.60 $16.80 10 141
Dec 21, 2016 $17.88 $17.88 $16.80 $17.16 3 003
Dec 20, 2016 $17.28 $19.44 $17.28 $17.88 10 899
Dec 19, 2016 $16.44 $17.64 $16.44 $17.28 7 006
Dec 16, 2016 $16.08 $16.20 $15.60 $16.20 4 752
Dec 15, 2016 $16.80 $16.80 $15.60 $15.84 7 259
Dec 14, 2016 $17.28 $17.40 $16.80 $16.80 4 043
Dec 13, 2016 $20.40 $20.52 $16.56 $17.52 16 468
Dec 12, 2016 $21.48 $21.48 $19.20 $19.32 9 541
Dec 09, 2016 $21.84 $21.84 $20.76 $21.48 3 746
Dec 08, 2016 $22.68 $22.68 $21.12 $21.60 8 444
Dec 07, 2016 $21.48 $23.28 $19.80 $22.44 17 458
Dec 06, 2016 $22.20 $23.28 $20.76 $21.48 8 834
Dec 05, 2016 $25.20 $25.44 $21.60 $22.56 28 601
Dec 02, 2016 $23.04 $25.80 $22.20 $24.96 36 907
Dec 01, 2016 $23.76 $25.32 $22.80 $23.52 17 955
Nov 30, 2016 $25.08 $28.80 $23.04 $24.48 41 068
Nov 29, 2016 $23.28 $31.20 $22.56 $25.80 124 323
Nov 28, 2016 $22.92 $24.72 $22.80 $23.28 6 531
Nov 25, 2016 $22.08 $24.48 $21.36 $23.52 12 516
Nov 23, 2016 $21.60 $23.88 $21.00 $21.48 5 314
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT